BamSEC and AlphaSense Join Forces
Learn More

Talphera Inc.

NASDAQ: TLPH    
Share price (1/7/25): $0.64    
Market cap (1/7/25): $10.9 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 10-Q 66 pages [***] Certain Information in This Document Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Asset Purchase Agreement Between Acelrx Pharmaceuticals, Inc. and Vertical Pharmaceuticals, LLC Dated as of March 12, 2023 Asset Purchase Agreement
12/34/56
EX-2.1
from 10-Q 111 pages Agreement and Plan of Merger by and Among Acelrx Pharmaceuticals, Inc., Acelrx Intermediate Sub, Inc., Acelrx Consolidation Sub, LLC, Lowell Therapeutics, Inc., and James Wilkie, as Stockholder Representative November 14, 2021
12/34/56
EX-2.1
from 8-K 26 pages Amendment No. 2 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 26 pages Amendment No. 2 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 25 pages Amendment No. 2 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 28 pages Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 27 pages Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 27 pages Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 134 pages Agreement and Plan of Merger Among: Acelrx Pharmaceuticals, Inc., a Delaware Corporation; Consolidation Merger Sub, Inc. a Delaware Corporation; and Tetraphase Pharmaceuticals, Inc., a Delaware Corporation Dated as of March 15, 2020
12/34/56
EX-2.1
from 8-K 134 pages Agreement and Plan of Merger Among: Acelrx Pharmaceuticals, Inc., a Delaware Corporation; Consolidation Merger Sub, Inc. a Delaware Corporation; and Tetraphase Pharmaceuticals, Inc., a Delaware Corporation Dated as of March 15, 2020
12/34/56